A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. - Wikidata - awgldk - TriplyDB

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

http://www.wikidata.org/entity/Q47982760

about

Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions Infection of dendritic cells by the Maedi-Visna lentivirus Mechanism of dichotomy between CD8+ responses elicited by apoptotic and necrotic cells Viral immune evasion due to persistence of activated T cells without effector function Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40 Viruses, dendritic cells and the lung Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand.Detection of progeny immune responses after intravenous administration of DNA vaccine to pregnant mice Expression and functional effects of Eph receptor tyrosine kinase A family members on Langerhans like dendritic cells Endothelial cells present antigens in vivo Consensus workshop on methods to evaluate developmental immunotoxicity.Immunologic aspect of ovarian cancer and p53 as tumor antigen.Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation Complement regulation of T-cell alloimmunity Complement regulation of T cell immunity Priming of CD8(+) T Cell Responses to Liver Stage Malaria Parasite Antigens CD40 immunotherapy for pancreatic cancer CD4 T-cell immunotherapy for chronic viral infections and cancer Effector mechanisms of rejection Specific medicinal plant polysaccharides effectively enhance the potency of a DC-based vaccine against mouse mammary tumor metastasis Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.Genealogical evidence for positive selection in the nef gene of HIV-1 CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy.Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis CD154-CD40 interactions in the control of murine B cell hematopoiesis The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens Ii-Key/MHC class II epitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines.

P2860

Q24313150-48BFEA86-B084-4D23-9175-559A64A20E9B Q24515069-02CF01BF-001F-46ED-857C-2FE719C97322 Q24629263-E08A98AB-3372-4534-9D7F-A933055CFEFD Q24646943-6BD024C6-6672-44C9-A66B-090D89AC8A87 Q24676338-4302C690-AEB7-46FE-BF2B-816499858C06 Q24792156-BAB3CA70-630E-4E14-A01E-E80F1A38C30B Q24794124-E317EAF7-0819-468A-89F9-748877FB8450 Q24797322-E61AB75B-4D0F-4586-82E7-724D1AAC3D61 Q24799713-DB70DDF7-5505-4E6B-B292-80334BD383B2 Q24805981-89A960A2-11BA-4028-99D4-0C74C5D1CD61 Q24814374-E332D761-FCCB-4CFA-B38F-232BCFF37430 Q24814703-5F0CC818-2406-4DFE-A691-8A700344B1D5 Q24815428-520CF88A-17DF-45F7-BDEA-BD254C91F16E Q26766411-BEA4DC7B-A14A-4CC1-99F5-C23E49C4836D Q26781522-6DFD5E66-961A-424A-81E2-90C4FAEBB6A8 Q26782520-DC30F78D-5E11-41A5-B2B0-D1572DC60529 Q26782583-44FAC7DF-0835-4972-BAF1-71A6AAF6A331 Q26797344-73105516-C8BD-43AE-A83C-E44604294CC4 Q26823956-C51EC441-822E-43DA-9E61-6ADFB83CC07F Q26827470-7C615B2E-8D21-4B05-B7C0-826717BD35D2 Q26997355-C4CFE010-1E2C-477E-A234-9C45DAD052FC Q27012550-5630C203-A548-40A9-B85B-63F1298E5D00 Q27022957-DE3A881E-F809-4193-B933-D250E59E483D Q27027082-4F81425E-1CFA-4F7A-9BA7-A211D55E3AD6 Q27310303-9AE7FEF4-1AD7-4933-BA03-ACF8A06CB57D Q27472925-C2746336-62E1-41EA-A72A-EE879BA115A7 Q27473192-1BD86135-3B1B-4D09-99E1-FB65CE7BC859 Q27481468-EF5DA9CC-5BD3-44FF-B61E-B75F54F9ECCC Q27485419-75132914-ABD1-4CCD-A0B5-C474A0E5E227 Q27490290-75B28480-05F7-4743-BC9E-21470BA343D0 Q27686800-597B5460-FDAD-4EE0-99B7-F671836C3110 Q28142813-547A4F24-F57C-4341-A360-44C5E0A4566D Q28243702-C7ECAEC6-0BF9-403F-9547-4676DD6EF65A Q28305580-CAB07167-2AE4-49A4-A2A8-1CC6C36300A1 Q28384138-BA98D3B0-2B05-4319-A0B5-9E8624AF6AB1 Q28609312-2A63C76D-870F-4ACF-A46A-61034E5C2871 Q28652288-66D33571-3944-49B4-93BC-8CF82B7405C4 Q29614348-AEB6C362-BDB0-4981-AC18-D0453AEC0C68 Q29615098-FABA3B85-42C9-4B60-B191-F93B79C3A000 Q30359230-D99DA931-CBDD-443E-A99E-0D608763590C

P2860

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

http://www.wikidata.org/entity/Q47982760

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

A conditioned dendritic cell c ...... T-helper and a T-killer cell.

@en

A conditioned dendritic cell c ...... T-helper and a T-killer cell.

@nl

type

label

A conditioned dendritic cell c ...... T-helper and a T-killer cell.

@en

A conditioned dendritic cell c ...... T-helper and a T-killer cell.

@nl

prefLabel

A conditioned dendritic cell c ...... T-helper and a T-killer cell.

@en

A conditioned dendritic cell c ...... T-helper and a T-killer cell.

@nl

P1433

Q47982760-11FA2DF4-4B46-4956-A7FB-63E44218814A

P1476

Q47982760-3BA77B40-176F-4582-AD37-04C5596256B9

P2093

Q47982760-35801559-C3F1-4620-8C74-C4DD0F2E3FB0

Q47982760-5491B49F-AFDE-4ECB-BC7B-48E8A9A0595A

P2860

Q47982760-032D53B9-6F23-4865-A4CE-A70058F5A8EC

Q47982760-0FC26482-3B39-4B23-877A-2983685FECED

Q47982760-2250C8BC-7DA0-4997-A4CE-3088988A69D6

Q47982760-23DCA790-ADFE-4775-8EA1-EE55F6036DA8

Q47982760-3212D75D-B70E-46C6-929E-84B071EAFA89

Q47982760-437EDC3A-6CEF-41F3-A2BF-79AF41D8C109

Q47982760-50DF2A8D-62D3-4FD4-89EF-2C3E32181B86

Q47982760-545C2F2E-29C9-45DD-9B3A-0863AD346FE0

Q47982760-5C2816E4-974D-4FC9-984F-861230B1048A

Q47982760-5CC2B72A-794E-4A47-9CE0-670A752CB201

P2888

Q47982760-944323F7-479A-4AE7-A12C-8B5F68399F91

P304

Q47982760-BBC6723E-5A7F-4EA3-AFA1-E0EC379B4B24

P31

Q47982760-31D6EDD9-48C5-4558-8BA7-EF6176F8D47D

P356

Q47982760-B6D801BE-AEC3-4C97-8C6E-772E5A1DA4D8

P407

Q47982760-B1E4D5D0-CC25-4BF7-BE2B-7EEC5F165338

P433

Q47982760-5C1ACD28-7FA7-4715-8F6C-AB941C6FFAD2

P478

Q47982760-30D04E61-6920-44A4-8B07-E732DC6E33EB

P50

Q47982760-1D51C938-C781-464E-A97D-D03BDD3879DC

P577

Q47982760-EDC685F8-5C08-4684-8C06-F9B744E707F1

P5875

Q47982760-45388CB4-6BF1-43FE-B770-EED8FB2352B1

P6179

Q47982760-30922400-02F4-48FE-BC56-57C72DEF722C

P698

Q47982760-66F2E434-D692-435F-B2EC-7C5DF29A960B

P356

P1433

P1476

A conditioned dendritic cell c ...... T-helper and a T-killer cell.

@en

P2093

Matzinger P

http://www.w3.org/2001/XMLSchema#string

Ridge JP

http://www.w3.org/2001/XMLSchema#string

P2860

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

Approaching the asymptote? Evolution and revolution in immunology

Tolerance, danger, and the extended family

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

T cell memory is short-lived in the absence of antigen

Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes

A fail-safe mechanism for maintaining self-tolerance

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

Human B cell precursors proliferate and express CD23 after CD40 ligation.

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help.

P2888

P304

474-478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/30989

http://www.w3.org/2001/XMLSchema#string

P407

P433

6684

http://www.w3.org/2001/XMLSchema#string

P478

393

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Di Rosa

P577

1998-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13660522

http://www.w3.org/2001/XMLSchema#string

P6179

1047483692

http://www.w3.org/2001/XMLSchema#string

P698

9624003

http://www.w3.org/2001/XMLSchema#string